Skip to content
Precision for Medicine
Contact Us
New Whitepaper

Beyond Geography: A Former Regulator’s Perspective on Multiregional Oncology Trials

Download Now
AdobeStock_183200379 AdobeStock_183200379

Clinical Trial Management Services

Execute your trials with Precision: Unrivaled Clinical Trial Management for global impact
Empower your clinical research with Precision for Medicine's bespoke Clinical Trial Management Services. Our approach seamlessly blends innovation in early-phase trials with robust effectiveness in late phases, ensuring your research advances confidently towards its goals. With an unwavering commitment to excellence, we propel the advancement of life-changing therapies for patients in need around the globe.

End-to-end Clinical Trial Management services

Precision for Medicine's end-to-end capabilities unite expert teams and global reach with advanced processes and technologies. By transforming complex data into actionable insights, we not only navigate the intricacies of each phase but also empower each trial with the agility and insight needed to drive success from concept to conclusion. Our strategic and collaborative approach to clinical trial management services accelerates trial success, setting new industry standards.

CRO Leadership Awards 2024

Award-winning clinical trial management services

Precision for Medicine's receipt of the 2024 CRO Leadership Awards in every category signifies more than our excellence; it highlights our partnership's value in propelling your clinical trials forward. Our award-winning expertise delivers not just superior trial management but a shared mission in bringing transformative therapies to patients globally.

See how our consistent recognition in the industry underscores our commitment to excellence in clinical trial management.

Explore our accolades
3500 Experts fueling innovation
600 Global trials driving progress
20 Years of clinical excellence

Advancing outcomes at every stage

  • Discover Early Phase Excellence
    clinical trial patient doctor

    Early Phase Excellence

    Embark on the critical first steps of clinical discovery with our expertly managed early phase trials, where meticulous attention meets innovative strategy.

    Explore
  • Discover Late Phase Success
    patient on bed clinical

    Late Phase Success

    Discover the path to market with our Late Phase Development expertise – delivering precision, compliance, and efficiency for your clinical journey.

    Explore

Deep experience with debilitating disease and unique modalities

Like you, we understand that there’s a patient throughout the development pathway. Supporting our partners to bring innovative treatments to patients is our purpose. Leverage our experience in these therapeutic areas.

Oncology Explore Rare Diseases Explore Autoimmune Explore Gene Therapy Explore Cell Therapy Explore

Specialized capabilities in every stage of clinical development

Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to accelerate speed to market. Precision can customize and converge our capabilities to meet your program's unique needs—driving efficiency, agility, and success from start to finish.

  • Discover Explore
    clinical-trial-support

    Global CRO Services

    A recognized leader in oncology and rare diseases with rich experience in complex trials

    Explore
  • Discover Explore
    specialty-lab-services

    Laboratory
    Services

    Experts in translational and biomarker sciences with worldwide specialty labs and central lab services that are enabling breakthroughs.

    Explore

Read our latest Precision insights

Stay updated with the latest insights in statistical programming and automation through our blog. 

Explore the blog
Read: Developing a Comprehensive Strategy for Implementing AI & Multi-Omics for Translational Research Developing a Comprehensive Strategy for Implementing AI & Multi-Omics for Translational Research

Translational Research

Developing a Comprehensive Strategy for Implementing AI & Multi-Omics for Translational Research

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=199448088864, hs_child_table_id=0, hs_updated_at=1762810484868, hs_published_at=1770252999853, avatar=Image{width=1200,height=1200,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Kaylee%20Mueller.png',altText='Kaylee Mueller',fileId=199456336149}, lastname=Mueller, hs_initial_published_at=1762810487482, hs_created_by_user_id=26433386, hs_created_at=1762810467146, hs_is_edited=false, hs_deleted_at=0, name=Kaylee, slug=kaylee-mueller, hs_updated_by_user_id=51739740}, second={}, third={}})
  • Kaylee Mueller avatar

    Kaylee Mueller
Discover
Read: The Collaborative Partnership Model: Your Team Amplified The Collaborative Partnership Model: Your Team Amplified

Clinical Trials

The Collaborative Partnership Model: Your Team Amplified

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=164725548848, hs_child_table_id=0, hs_updated_at=1754641451547, hs_published_at=1770252999853, description=Alexis Hobbins-White is an accomplished leader who plays a pivotal role in navigating the complex landscape of global oncology and rare disease-focused clinical trials. With a career spanning over 15 years in the clinical trials industry, Alexis brings a wealth of experience across multiple therapeutic areas, showcasing her proficiency in diverse aspects of operational strategy. She specializes in early phase adaptive studies, particularly in immuno-oncology and advanced therapeutics. She has an MSc in Neuroscience and an MA in Biotechnology Law and Ethics., avatar=Image{width=287,height=287,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/Alexis-Hobbins.png',altText='Alexis-Hobbins',fileId=194096322982}, linkedin=https://www.linkedin.com/in/alexis-hobbins-white-400a1720/, lastname=Hobbins-White, hs_initial_published_at=1713362276020, hs_created_by_user_id=5166971, hs_created_at=1713361952861, hs_is_edited=false, hs_deleted_at=0, name=Alexis, job=Senior Director, Operational Strategy , slug=alexis-hobbins-white, hs_updated_by_user_id=51739740}, second={}, third={}})
  • Alexis Hobbins-White avatar

    Alexis Hobbins-White
Discover
Read: EMA PRIME Scheme Explained: Eligibility, Benefits, Risks, and When to Apply EMA PRIME Scheme Explained: Eligibility, Benefits, Risks, and When to Apply

Clinical Trials - Regulatory

EMA PRIME Scheme Explained: Eligibility, Benefits, Risks, and When to Apply

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=195804116748, hs_child_table_id=0, hs_updated_at=1764696930757, hs_published_at=1770252999853, description=John is an experienced regulatory affairs consultant with more than 15 years of professional experience in drug development. He brings a proven track record in providing regulatory strategy, regulatory document development and review, and liaising with regulatory authorities., avatar=Image{width=276,height=290,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/John%20McIntyre.png',altText='John McIntyre',fileId=201584594055}, lastname=McIntyre, PhD, hs_initial_published_at=1757516163742, hs_created_by_user_id=26433386, hs_created_at=1757515873736, hs_is_edited=false, hs_deleted_at=0, name=John, job=Senior Director, Regulatory Strategy, slug=john-mcintyre, hs_updated_by_user_id=51739740}, second={hs_id=159488778852, hs_child_table_id=0, hs_updated_at=1765558855468, hs_published_at=1770252999853, description=Chris Ingram, BSc (Hons) is Head of Regulatory Consultancy (Europe) for Precision for Medicine. Chris received his BSc(Hons) in immunology and pharmacology from the University of Strathclyde and has since spent over 21 years working in regulatory affairs with a focus on clinical development. Chris’ regulatory expertise covers clinical development across all phases, regulatory strategy, marketing authorisations, scientific advice, orphan drug designation and paediatric investigation plans across a wide variety of therapeutic areas, including but not limited to, oncology, CNS, metabolic, endocrinology, analgesia and cardiovascular., avatar=Image{width=1200,height=1200,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Chris-Ingram.png',altText='Chris-Ingram',fileId=202456722303}, linkedin=https://www.linkedin.com/in/chris-ingram-0255b216, hs_name=, hs_path=, lastname=Ingram, hs_initial_published_at=1769114824102, hs_created_at=1709645745083, hs_is_edited=false, hs_deleted_at=0, name=Chris, job=Executive Director, Regulatory Affairs, Europe, slug=chris-ingram, email=, hs_updated_by_user_id=51739740}, third={}})
  • John M. avatar

    John M.
  • Chris I. avatar

    Chris I.
Discover
Loading...